Synthetic hair marketed toward Black women contains carcinogens and lead, report finds
Ingredients that can cause cancer were found in 10 synthetic hair products used in braids, extensions and other hairstyles popular with Black women, including artificial hair from popular brands such as Magic Fingers, Sensationnel and Shake-N-Go, according to a Consumer Reports study published Thursday.
Lead, which can cause serious health and developmental problems, was also found in nine of the 10 packs of synthetic hair surveyed, including one package of braiding hair that exceeded the maximum allowed dose of lead by more than 600%, according to the study. Consumer Reports used California's maximum allowable dosage level, describing it as the 'most protective available in the U.S.,' because there are no federal limits on lead in synthetic braiding hair.
Synthetic hair has long been a staple in protective hairstyles for Black women — like braids, locs and twists. These styles can be worn for weeks at a time, protecting the hair from breakage, exposure to the elements or day-to-day heat styling. This translates to longer exposure to the chemicals, Consumer Reports said.
Synthetic hair is commonly found at neighborhood beauty supply stores and online. Consumer Reports researchers assessed braiding hair from 10 companies, many of which use synthetic hair made from Kanekalon, a material produced by the Kaneka brand, according to Consumer Reports.
Kaneka did not immediately respond to NBC News' request for comment, but told Consumer Reports, 'Kaneka only manufactures the Kanekalon fibers that are used in various hair products, such as synthetic hair braids and wigs, and does not produce any of the final products.' The braiding hair companies themselves dye and style the Kanekalon, Kaneka added. The company also told Consumer Reports it would need more information to properly analyze the complaint.
Sensationnel, Magic Fingers and other products contain benzene, known to be a cancer-causing ingredient, according to the study. The chemical likely causes acute myeloid leukemia, according to the American Cancer Society.
Consumer Reports also found methylene chloride, which the EPA says can lead to liver and lung cancer after chronic exposure. No level of methylene chloride is permitted in cosmetics by the Food and Drug Administration.
'There is no safe level of exposure to lead or benzene,' Alexa Friedman, a senior scientist for the Environmental Working Group, a research and advocacy health organization, said. 'When possible, exposure to either chemical should be avoided as they are associated with serious health effects.'
Nine of the 10 products tested also contained lead, the report found. Lead can cause a number of developmental disabilities in children, as well as reproductive issues in adults, according to the Centers for Disease Control and Prevention.
'There are no federal limits on the amount of lead in synthetic braiding products,' Friedman said. 'Lead is not permitted to be intentionally added to cosmetic products in the US but may be present as a contamination of certain ingredients.'
Magic Fingers, Sensationnel and Shake-n-Go did not immediately respond to NBC News' requests for comment.
Magic Fingers told Consumer Reports that its customers 'can count on us for braids and extensions that meet their highest expectations for fashion and performance.'
Sensationnel told Consumer Reports, 'We unequivocally stand by the safety of Sensationnel products.'
'While most of these products are below the FDA standard for lead contamination in cosmetics, when possible exposure to lead should be avoided,' Friedman said.
Both Magic Fingers and Sensationnel did not agree with the methodology used to test the products, saying it was not representative of consumers' use of the products. Consumer Reports tested 10 artificial braiding hair products and a total of 20 samples, blind-coding them and sending them to a laboratory for heavy metal analysis. Shake-n-Go did not respond to Consumer Reports' request for comment.
In 2022, companies that make chemical hair relaxers, which straighten hair, were sued in a class-action lawsuit by hundreds of Black people who said the products led to uterine cancer. Several wide-scale studies have been published in recent years showing heightened rates of cancer, infertility and other illnesses among women who use chemical hair relaxers, which are generally marketed to Black women.
Friedman said the Consumer Reports study highlights an 'alarming trend' of toxic products being marketed toward Black women, which the organization tracks.
'On average, women use 12 personal care products a day, which can expose people to mixtures of harmful chemicals,' Friedman said in a statement, 'And studies show that repeated exposure to mixtures of chemicals can pose far greater health risks than exposure to a single ingredient.'
EWG tested more than 4,000 products marketed toward Black women and found that most of them were at least moderately, if not highly, hazardous to human health. EWG has developed a database, Skin Deep, where consumers can look up beauty products and see whether they're classified as low, moderately or highly hazardous by the group.
'Everyone deserves access to safe products,' Friedman said. 'Manufacturers should prioritize safety for consumers.'
This article was originally published on NBCNews.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
RFK Jr.'s policies will make America's maternal mortality rates worse
The American College of Obstetricians and Gynecologists rightly criticized Health and Human Services Secretary Robert F. Kennedy Jr.'s announcement at the end of last month that his department will no longer recommend the Covid vaccine for pregnant women. Covid was the leading cause of maternal mortality in 2021, and the ACOG correctly pointed out that the vaccine is safe and that it provides needed protection for expectant mothers and their unborn children. The decision by Kennedy's agency to delete the recommendation that pregnant women be vaccinated against a virus that was recently the leading cause of maternal death should prompt us to ask: Where are pregnant women in Kennedy's 'Make America Healthy Again' plan? As a maternal health physician, public health expert and equity leader, I'm as unhappy as ACOG is with the specific decision the HHS has made to stop recommending the Covid vaccine for my pregnant patients. Contracting Covid during pregnancy increases the risk of complications, including death. But I'm even more outraged and alarmed by something else HHS has done on Kennedy's watch: omit maternal mortality review committees (MMRCs) and perinatal quality collaboratives (PQCs) from the new structure of HHS. Maternal mortality review committees show us what is killing mothers and how we can stop it. Perinatal quality collaboratives give us the tools to act. They help hospitals and providers implement lifesaving solutions. These programs are not bureaucratic add-ons, but the main reason our nation has made progress in reducing maternal deaths. And yet, in a new proposed budget, programs run by the Centers for Disease Control and Prevention, such as the pregnancy risk assessment monitoring system, maternal mortality review committees and perinatal quality collaboratives are conspicuously missing. Together, these programs have led to measurable improvements in maternal outcomes across the country. From 2021 to 2023, the U.S. saw statistically significant decreases in maternal mortality. That's not a coincidence — it's the result of a national, coordinated strategy rooted in evidence and accountability. The removal of this infrastructure is more than a policy shift — it's a dismantling of the very system that allowed us to fight back against a maternal health crisis. And the stakes are especially high for Black women and rural mothers, who face the greatest disparities in maternal outcomes. Without MMRCs, we lose the ability to track those disparities. Without PQCs, we lose the mechanism to fix them. In smaller hospitals, especially, quality improvement isn't a given — it's something PQCs make possible by helping teams implement patient safety bundles that might otherwise remain unused. Forty-six states and six U.S. territories have MMRCs supported by a CDC grant. This funding provides support to perform case reviews of maternal deaths, while the CDC provides the infrastructure, including a database that allows the results of such reviews to be aggregated. Data from MMRCs in 38 states in 2020, for example, showed that the leading cause of pregnancy-related deaths was mental health conditions, inclusive of suicide and accidental overdose, and 84% of those deaths were deemed preventable. Those findings gave rise to federal programs such as the maternal mental health hotline which, I'm thankful, will continue to be supported in the proposed HHS budget. The CDC also provides funding to support 36 state-based PQCs. This is an example of how the programs work together: In Louisiana, our maternal mortality review identified obstetric hemorrhage as our leading cause of pregnancy-related deaths in 2018. As a result, the Louisiana Perinatal Quality Collaborative (LaPQC) through the reducing maternal morbidity initiative and the safe births initiative worked to implement the AIM obstetric hemorrhage patient safety bundle. As a result, Louisiana mothers experiencing hemorrhage saw a 39% decrease in severe maternal morbidity (SMM), with a 58% decrease among Black women. These aren't anecdotes. They are blueprints for saving lives. Like the decision to stop recommending the Covid vaccine, if the decision to remove these programs from the budget stands, we will reverse course. The U.S. already has the highest maternal mortality rate among high-income countries. Removing these programs is likely to make the national crisis worse. We cannot allow that. My message to policymakers is simple: You can't 'Make America Healthy Again' if you ignore the risks of pregnancy and childbirth. Reinvest in the programs that are working. Fund the programs that show us why mothers are dying and what to do to keep more mothers alive. Preserve the public health infrastructure that has already started to move the needle in the right direction. If we as a country fail to act, then more mothers will die — and the tragic part is, we'll know we had the tools to prevent it. This article was originally published on
Yahoo
5 hours ago
- Yahoo
From HIV to Hormone Therapy, Medicaid Cuts Threaten Atlanta's LGBTQ+ Community
As lawmakers push for sweeping cuts to Medicaid, fear weighs heavily on Tori Cooper. Cooper, a trans woman who serves as the director of strategic outreach and training for the Human Rights Campaign, told Capital B Atlanta that for her and other Black trans residents, these cuts will have a detrimental impact on their lives. 'The Black LGBTQ community will be greatly impacted, and Black trans folks even more so,' said Cooper. 'For years, we've acknowledged how systematic racism impacts the lives of Black LGBTQ people. Inequity and racist ideology and policies have traditionally led to worse health outcomes for poor, less educated, underemployed people and those of us who live in the South.' Last month, congressional House Republicans passed a bill that would cut billions over the next 10 years from Medicaid, the federal-state health care insurance program that helps pay for health care for low-income people. The bill also would prohibit gender transition care from being covered by the program. 'I worry that preventable health conditions like HIV will ravage my community,' Cooper said. 'I worry that Black trans people will lose some of the social and political traction that our transestors fought for. I worry that my Black trans family will have to go back into the proverbial closet for safety. Closets are made for clothes, not people.' Cooper worries that in a place like Georgia, where HIV rates are high and access to health care is already difficult due to the Georgia General Assembly's refusal to expand Medicaid, the Black LGBTQ+ community will be one of the vulnerable and bear the brunt of these looming cuts. In 2023, about 1 in every 4 Black Georgians was covered by Medicaid, compared to about 1 in every 10 white Georgians, according to the State Health Access Data Assistance Center. Nationally, Black LGBTQ residents are twice as likely to be enrolled in Medicaid compared to the general population, Victoria Kirby York, director of public policy and programs for the National Black Justice Coalition, told Capital B Atlanta. York said she's fearful that critical areas of health care for Black LGBTQ+ residents such as gender-affirming care, mental health services, and substance abuse treatment will all be impacted by the Medicaid cuts. 'Thirty-two percent of [LGBTQ people] versus 15% of the general population use Medicaid in order to access health care, and that number is even higher for transgender members of our community, where 45% of the community are relying on Medicaid,' York said. Although Georgia is one of the 10 states that did not expand Medicaid, leaving hundreds of thousands of residents uninsured, the proposed budget cuts will still be felt. The state could potentially lose billions in federal Medicaid funding, and hundreds of thousands of Georgians could lose Medicaid coverage over the next 10 years, according to reporting from the Kaiser Family Foundation. Matthew Rose, senior public policy advocate with the Human Rights Campaign, told Capital B Atlanta these cuts will put a strain on the state's budget, resulting in a push by state lawmakers to make 'draconian' decisions on how to further cut costs. This could mean cutting back on some of the optional health services and medicines provided underneath Medicaid in Georgia, such as HIV preventative medications or mental health services, or lawmakers could tighten eligibility requirements so fewer residents are covered by the insurance program. When it comes to HIV, Maxx Boykin, the campaign manager for Save HIV Funding, told Capital B Atlanta he worries Medicaid cuts could exacerbate the already high HIV transmission rates in the state, as many people living with HIV rely on Medicaid for medication and wraparound services like home health care and therapy. Read More: CDC Cuts HIV Communications, Leaving Vulnerable Black Georgians in the Dark According to the Kaiser Family Foundation, Medicaid is the largest source of insurance coverage for people with HIV in the United States, covering an estimated 40% of the nonelderly adults with HIV, compared to just 15% of the nonelderly adult population overall. According to the CDC, Georgia had the second-highest HIV diagnosis rate and the second-highest rate of HIV related deaths in 2023 in the U.S. Additionally, Georgia had the highest rate of new HIV infections in 2022. In addition, despite constituting about 32% of Georgia's population, Black people accounted for approximately 71% of new HIV diagnoses in 2021. 'When thinking about HIV, that means less people will have access to the medications that they need, and we will see an even larger spread of HIV in our communities, and a big part of that will be because the majority of people living with HIV actually need Medicaid,' said Boykin. Maisha Standifer, the director of population health at the Satcher Health Leadership Institute at the Morehouse School of Medicine, said the elderly and those with disabilities shouldn't be forgotten when thinking about Medicaid and the LGBTQ community. According to the Human Rights Campaign, in the U.S., LGBTQ+ adults, and transgender adults in particular, were significantly more likely than non-LGBTQ+ adults to self-report having at least one disability. Standifer said that for Georgia's Medicaid program, people ages 65 and older and people with disabilities account for more than half of the state's $16 billion Medicaid spending. 'We have community partners who are 30-plus years living with HIV and aging. So with aging naturally comes other chronic conditions. We're talking about diabetes, cancer, heart disease,' said Standifer. The cuts to Medicaid are part of the Trump administration's efforts to curb federal spending to offset the cost of extending the president's 2017 tax cuts for high-income earners. Of further concern to Rose with the Human Rights Campaign is the impact on the LGBTQ community when the Medicaid cuts are layered on top of the proposed SNAP cuts in the bill, creating even more harm to LGBTQ people's health. 'We've seen the result of what hunger can do, which is why we feed people, why we created these programs in the first place, and the SNAP cuts would be devastating. … Then you tack them on to the fact that you're not eating as much, which weakens your immune system, and so it makes it easier for you to get sick, so it's a compounding issue,' said Rose. While the Medicaid cuts are still under review in the Senate, advocates are encouraging anyone in opposition to the cuts to reach out to their representatives and share their concerns about the proposed legislation. 'We need to hold our elected officials accountable, both on the federal side, the state side, and our local side, to make sure they're actually doing what's right for folks,' said Boykin. The post From HIV to Hormone Therapy, Medicaid Cuts Threaten Atlanta's LGBTQ+ Community appeared first on Capital B News - Atlanta.
Yahoo
9 hours ago
- Yahoo
‘Problematic' MAHA report minimizes success of lifesaving asthma medicines, doctors say
Teens play basketball outside on a hot day in summer 2023 in New York City after the state issued an air quality health advisory recommending active children and those with asthma limit time outside. Experts worry that a new federal report minimizes how millions of kids in the U.S. rely on asthma medications to breathe normally. (Photo by) Medical experts are dismayed over a federal report's claim that kids are overprescribed asthma medications, saying it minimizes how many lives the drugs save. Safe treatment protocols for asthma management have been carefully studied over the years, said Dr. Perry Sheffield, a pediatrician and professor at the Icahn School of Medicine at Mount Sinai. 'The federal government actually has some really beautiful and clear guidelines and strategies, and things that are vetted by and carefully edited by many experts in the field,' said Sheffield, who co-directs a region of the federally funded Pediatric Environmental Health Specialty Units that serves New Jersey, New York, Puerto Rico and the U.S. Virgin Islands. Asthma affects more than 4.6 million American children, according to the federal Centers for Disease Control and Prevention. It's one of the most common long-term diseases in U.S. children. The Make America Healthy Again Commission report released in late May, parts of which have been widely criticized, alleges that American children are on too much medication of various kinds, including asthma treatments. Experts worry that the administration will set policy based on the assessment, dissuading insurers from covering asthma prescriptions. They also say that the report's assertions could worsen disparities that affect children's access to those medications and undermine years of research around the drugs. Blue Cross Blue Shield now requires prior approval for severe asthma drugs in some states The MAHA commission has until August to release a strategy based on the findings in the report. Black and Indigenous children as well as those living in inner cities or in lower-income households are among those with the highest rates of asthma. Pollution disproportionately shrouds communities of color and can be a trigger that exacerbates the disease. The report's message could heighten those disparities, said Dr. Elizabeth Matsui, a University of Texas at Austin professor and a past chair of the American Academy of Pediatrics' Section on Allergy and Immunology. 'One thing that has been very clear is that kids of color are less likely to be appropriately managed in terms of their asthma medication management,' she said. 'So a message of overprescription that is simply not supported by the evidence also could potentially exacerbate already-existing racial and ethnic disparities in asthma that we have really not made much headway on.' The report touches on childhood prediabetes, obesity and mental health. However, firearm injuries — the leading cause of death for children and teens in 2020 and 2021, according to the CDC — weren't mentioned. The 70-page report from the commission, chaired by Secretary of Health and Human Services Robert F. Kennedy Jr., claims four main issues are the drivers behind childhood chronic disease: poor diet, aggregation of environmental chemicals, lack of physical activity and chronic stress, and 'overmedicalization.' Matsui and other experts said the report's use of that word is 'problematic.' 'The implication could be, unfortunately, that when a child has asthma — so, they have coughing, chest tightness, wheezing — that that is not really a disease,' said Matsui. 'We know for a fact that that's a disease, and we know that it is quite treatable, quite controllable, and that it has profound impacts on the child's day-to-day life.' Other scientists have similarly criticized the report, saying it makes sweeping and misleading generalizations about children's health without sufficient evidence. The White House corrected the report after nonprofit news outlet NOTUS found that it cited studies that didn't exist. The implication could be, unfortunately, that when a child has asthma … that that is not really a disease. We know for a fact that that's a disease. – Dr. Elizabeth Matsui, University of Texas at Austin professor When it comes to asthma, the report says, 'Asthma controller prescriptions increased 30% from 1999-2008.' That sentence originally cited a broken link to a study from 2011; the link was later replaced. Controller meds include inhalers. The MAHA report also claims that 'There is evidence of overprescription of oral corticosteroids for mild cases of asthma.' The original version of the report listed estimated percentages of oral corticosteroids overuse, citing a nonexistent study. The wording was changed and the citation was later replaced with a link to a 2017 study by pediatric pulmonologist Dr. Harold Farber. The study was not a randomized controlled trial, which increases reliability. Farber told NOTUS that the report made an 'overgeneralization' of his research. Stateline also reached out to Farber, whose public relations team declined an interview request. Oral corticosteroids are liquid or tablet medications used to reduce inflammation for conditions including allergies, asthma, arthritis and Crohn's disease. For asthma, they're used to treat severe flare-up episodes. The Asthma and Allergy Foundation of America says the medications have been shown to reduce emergency room visits and hospitalizations, and that while they do come with risk of side effects, they're mostly used in acute flare-ups. And while rare, asthma-related deaths in kids do occur, and are often preventable. 'Asthma medications, including oral steroids, are lifesaving,' said Dr. Elizabeth Friedman, a pediatrician at Children's Mercy Kansas City. 'I believe that physicians, not politicians, are best equipped and most effectively trained to make the determination of whether or not these medications are needed for our patients.' Friedman worries that federal characterizations of asthma meds will affect how state Medicaid agencies cover the drugs. When Medicaid coverage changed for a common prescribed inhaler last year, many of her Missouri Medicaid patients were suddenly without the drug. They ended up hospitalized, she said. Friedman directs Region 7 of the Pediatric Environmental Health Specialty Units, a network of experts that works to address reproductive and children's environmental health issues. Region 7 provides outreach and education in Iowa, Kansas, Missouri and Nebraska. She also said she's concerned that the report is 'making a broad, sweeping statement based on one epidemiologic study from one state.' An increase in inhaler prescriptions is not necessarily a bad thing, experts say. It's a sign that kids are getting their medication. There has been an increase in inhaler prescriptions, along with a corresponding decrease in the oral corticosteroids, which is what experts would want to see, said Chelsea Langer, bureau chief of the New Mexico Department of Health's Environmental Health Epidemiology Bureau. She said that means kids are 'following their asthma action plans and taking the controller medications to prevent needing the relief or treatment [oral] meds.' Trump has canceled environmental justice grants. Here's what communities are losing. Asthma prevalence has increased over the years, meaning more people need medication, noted Dr. Alan Baptist, division head of Allergy and Clinical Immunology at Henry Ford Health in Michigan. He said that because steroid tablets come with risk of side effects, it is best to limit them. But for kids without access to a regular pediatric provider or to health insurance that covers an inhaler, cost can be an obstacle, he said. Fluticasone propionate, an FDA-approved medicine for people 4 and older, costs on average $200 or more for one inhaler without insurance. 'What often happens with kids, and especially kids who are in Medicaid, or who are in an underserved or disadvantaged population, they are not given appropriate asthma controller medication,' said Baptist, who helped write federal guidelines for asthma treatment best practices as part of a National Institutes of Health committee. Baptist noted that while he was glad to see pollution mentioned in the report as a danger for kids, it's at odds with the recent cuts to environmental health grants that aimed to address such asthma triggers. 'They're somewhat cherry-picking some of the data that they're putting down,' he said. 'It says the U.S. government is 'committed to fostering radical transparency and gold-standard science' to better understand the potential cumulative impacts of environmental exposure. If that's what they're saying, then they should be funding even greater studies that look at the effects.' Dr. Priya Bansal, an Illinois pediatrician and past president of the Illinois Society of Allergy, Asthma and Immunology, said she's concerned the report doesn't define mild, moderate or severe asthma to differentiate the different best-practice treatment plans. Bansal also said she worries that federal officials' characterization of an FDA-approved drug will lead to insurance companies refusing to cover inhalers or oral steroids for her patients who rely on them. 'I'm going to be worried about coverage for my asthmatics,' she said. 'The question is, what's the next move that they're going to make? If they think that, are they going to now say, 'Hey, we're not going to cover inhalers for mild asthmatics'?' Stateline reporter Nada Hassanein can be reached at nhassanein@ SUPPORT: YOU MAKE OUR WORK POSSIBLE
